The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Uncovering the differential impact of ESR1 and PIK3CA codon variants on the clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS).
 
Lorenzo Gerratana
Consulting or Advisory Role - Lilly; Novartis
Travel, Accommodations, Expenses - Menarini Silicon Biosystems
 
Andrew A. Davis
No Relationships to Disclose
 
Marko Velimirovic
Stock and Other Ownership Interests - Abbvie; Amgen
 
Paolo D'Amico
No Relationships to Disclose
 
Ami N. Shah
No Relationships to Disclose
 
Katherine Clifton
No Relationships to Disclose
 
Qiang Zhang
No Relationships to Disclose
 
Charles Sichao Dai
No Relationships to Disclose
 
Carolina Reduzzi
No Relationships to Disclose
 
Whitney L Hensing
No Relationships to Disclose
 
Marta Bonotto
No Relationships to Disclose
 
Roberta Mazzeo
No Relationships to Disclose
 
Firas Hazem Wehbe
No Relationships to Disclose
 
Alessandra Franzoni
Consulting or Advisory Role - Lilly (I); Novartis (I)
 
Barbara Belletti
No Relationships to Disclose
 
Amir Behdad
Honoraria - Bayer; Lilly; Roche China; Thermo Fisher Scientific
Speakers' Bureau - Bayer; Lilly; Roche China; Thermofisher Scientific Biomarkers
Travel, Accommodations, Expenses - Bayer; Foundation Medicine; Pfizer
 
Cynthia X. Ma
Consulting or Advisory Role - Agendia; AstraZeneca; Athenex; Bayer; Biovica; Eisai; Novartis; Olaris; Philips Electronics; Puma Biotechnology; Sanofi; Seagen
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Massimo Cristofanilli
Honoraria - Foundation Medicine; Pfizer
Consulting or Advisory Role - CytoDyn; Foundation Medicine; Lilly; Menarini; Novartis
Research Funding - Angle; Lilly; Merck